Inotiv Inc NOTV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $0.17
- Day Range
- $0.11–0.14
- 52-Week Range
- $0.08–3.19
- Bid/Ask
- $0.07 / $0.07
- Shares Outstanding
- 34.89M
- Market Cap
- $3.88M
- Volume/Avg
- 4M / 19M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.01
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 2,046
- Website
- https://www.inotivco.com
Valuation
|
Metric
|
NOTV
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.05 |
Price/Sales | 0.01 |
Price/Cash Flow | — |
Price/Earnings
NOTV
Financial Strength
|
Metric
|
NOTV
|
|---|---|
Quick Ratio | 0.17 |
Current Ratio | 0.27 |
Interest Coverage | −0.86 |
Quick Ratio
NOTV
Profitability
|
Metric
|
NOTV
|
|---|---|
Return on Assets (Normalized) | −10.67% |
Return on Equity (Normalized) | −63.86% |
Return on Invested Capital (Normalized) | −5.58% |
Return on Assets
NOTV
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Kdvrvsvz | Gdc | $175B | |||
| Danaher Corp
DHR
| Nglyxcwdl | Ynvkg | $130B | |||
| IDEXX Laboratories Inc
IDXX
| Rtvbnrwt | Vflg | $44B | |||
| Agilent Technologies Inc
A
| Ynqqvzywnp | Nqvlv | $37B | |||
| Waters Corp
WAT
| Sfgwshqc | Jnmwz | $36B | |||
| IQVIA Holdings Inc
IQV
| Vdchlbf | Zdxhhch | $31B | |||
| Illumina Inc
ILMN
| Qnzpsrpns | Xtfzc | $24B | |||
| Mettler-Toledo International Inc
MTD
| Fdcfsjtqg | Ftlctg | $23B | |||
| Quest Diagnostics Inc
DGX
| Zwnbvkyz | Mxztk | $22B | |||
| Labcorp Holdings Inc
LH
| Lrdkdpvvg | Jtwxws | $21B |
United States